The Good, the Bad, and the Ugly
Fund: Versant Ventures
Posted by MedTech Expert on 2007-12-03
Versant has a lot of good - good track record in the life sciences, experienced venture investors with start-up operating experience, and plenty of investment capital. It also has some bad - avoids most seed stage investments (too much risk), and avoids smallish investments in favor of putting larger amounts of money to work (the larger the fund...the larger the investment and existing shareholder dilution). And of course, there is the ugly - Becky appears to have some baggage. I have heard her trash companies and people she has not firsthand knowledge of. She appears to be one of those highly opinionated people who makes up her mind and does not want to be confused by the facts.
PRIVATE: Members Only